University of Miami Sylvester Comprehensive Cancer Center — Miami, Florida

Public research footprint of University of Miami Sylvester Comprehensive Cancer Center, compiled from the ClinicalTrials.gov public registry.

272

Registered studies

Active

Recruiting now

144

Completed

Stopped or withdrawn

Most-studied conditions

NSCLC · Recurrent Malignant Female Reproductive System Neoplasm · Locally Advanced Malignant Solid Neoplasm · Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

Recently updated registry entries

NCT05886036 — Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in… (Recruiting)
NCT06126276 — Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted… (Recruiting)
NCT02339571 — A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Miami Sylvester Comprehensive Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.